These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16546490)

  • 1. Statins attenuate sepsis.
    Spitzer AL; Harris HW
    Surgery; 2006 Mar; 139(3):283-7. PubMed ID: 16546490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin reduces endotoxin-induced nuclear factor kappaB activation and mortality in guinea pigs despite lowering circulating low-density lipoprotein cholesterol.
    Fraunberger P; Gröne E; Gröne HJ; Walli AK
    Shock; 2009 Aug; 32(2):159-63. PubMed ID: 19008785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins: the next anti-endotoxin.
    Kruger PS
    Crit Care Resusc; 2006 Sep; 8(3):223-6. PubMed ID: 16930109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104).
    Han J; Parsons M; Zhou X; Nicholson AC; Gotto AM; Hajjar DP
    Circulation; 2004 Nov; 110(22):3472-9. PubMed ID: 15557368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins in sepsis.
    Dobesh PP; Swahn SM; Peterson EJ; Olsen KM
    J Pharm Pract; 2010 Feb; 23(1):38-49. PubMed ID: 21507792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1.
    Li D; Chen H; Romeo F; Sawamura T; Saldeen T; Mehta JL
    J Pharmacol Exp Ther; 2002 Aug; 302(2):601-5. PubMed ID: 12130721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between statins and PPARalpha in cardiovascular diseases: clinical evidence and basic mechanisms.
    Paumelle R; Staels B
    Trends Cardiovasc Med; 2008 Apr; 18(3):73-8. PubMed ID: 18436144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do statins control neuroinflammation?
    Adamson P; Greenwood J
    Inflamm Res; 2003 Oct; 52(10):399-403. PubMed ID: 14520514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W; Köenig W
    J Cardiovasc Risk; 2003 Jun; 10(3):169-79. PubMed ID: 12775949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid composition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with systemic inflammatory response syndrome and multiple organ failure.
    Levels JH; Lemaire LC; van den Ende AE; van Deventer SJ; van Lanschot JJ
    Crit Care Med; 2003 Jun; 31(6):1647-53. PubMed ID: 12794399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotropic effects of statins and related pharmacological experimental approaches.
    Alegret M; Silvestre JS
    Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (TTA)n polymorphism in 3-hydroxy-3-methylglutaryl-coenzyme A and response to atorvastatin in coronary artery disease patients.
    Noriega V; Pennanen C; Sánchez MP; Chiong M; Llancaqueo M; Lavandero S; Prieto JC
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):211-5. PubMed ID: 19067673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pleiotrophic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors)].
    Igel M; Sudhop T; von Bergmann K
    Arzneimittelforschung; 2003; 53(8):545-53. PubMed ID: 13677244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-lowering and antiatherosclerotic effect of NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits.
    Suzuki H; Yamazaki H; Aoki T; Kojima J; Tamaki T; Sato F; Kitahara M; Saito Y
    Arzneimittelforschung; 2000 Nov; 50(11):995-1003. PubMed ID: 11187394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
    Bullano MF; Wertz DA; Yang GW; Kamat S; Borok GM; Gandhi S; McDonough KL; Willey VJ
    Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of statins and diabetes mellitus.
    Hagedorn J; Arora R
    Am J Ther; 2010; 17(2):e52-5. PubMed ID: 20019585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluvastatin prevents renal injury and expression of lactin-like oxidized low-density lipoprotein receptor-1 in rabbits with hypercholesterolemia.
    Yu YH; Wang Y; Dong B; Sun SZ; Chen Y; Meng XH; Liu ZZ
    Chin Med J (Engl); 2005 Apr; 118(8):621-6. PubMed ID: 15899115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Bocan TM
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-atherosclerotic actions of HMG-CoA reductase inhibitors].
    Gmiński J; Wojakowski W
    Przegl Lek; 1997; 54(11):782-7. PubMed ID: 9501689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.